BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lembo A, Zakko SF, Ferreira NL, Ringel Y., Bortey E, Courtney K, Corsi E, Forbes WP, Pimentel M. T1390 Rifaximin for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome: Short Term Treatment Leading to Long Term Sustained Response. Gastroenterology 2008;134:A-545. [DOI: 10.1016/s0016-5085(08)62544-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Lembo A, Sultan S, Chang L, Heidelbaugh JJ, Smalley W, Verne GN. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea. Gastroenterology 2022;163:137-51. [PMID: 35738725 DOI: 10.1053/j.gastro.2022.04.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Good L, Rosario R, Panas R. New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin. World J Gastroenterol 2015; 21(11): 3361-3366 [PMID: 25805945 DOI: 10.3748/wjg.v21.i11.3361] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]